102 related articles for article (PubMed ID: 14575358)
1. Reproductive factors in relation to breast cancer characterized by p53 protein expression (United States).
Furberg H; Millikan RC; Geradts J; Gammon MD; Dressler LG; Ambrosone CB; Newman B
Cancer Causes Control; 2003 Sep; 14(7):609-18. PubMed ID: 14575358
[TBL] [Abstract][Full Text] [Related]
2. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436
[TBL] [Abstract][Full Text] [Related]
3. Environmental factors in relation to breast cancer characterized by p53 protein expression.
Furberg H; Millikan RC; Geradts J; Gammon MD; Dressler LG; Ambrosone CB; Newman B
Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):829-35. PubMed ID: 12223426
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer among young U.S. women in relation to oral contraceptive use.
White E; Malone KE; Weiss NS; Daling JR
J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
[TBL] [Abstract][Full Text] [Related]
5. Cigarette smoking and other risk factors in relation to p53 expression in breast cancer among young women.
Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):255-63. PubMed ID: 10090304
[TBL] [Abstract][Full Text] [Related]
6. Oral contraceptives and breast cancer risk among younger women.
Brinton LA; Daling JR; Liff JM; Schoenberg JB; Malone KE; Stanford JL; Coates RJ; Gammon MD; Hanson L; Hoover RN
J Natl Cancer Inst; 1995 Jun; 87(11):827-35. PubMed ID: 7791232
[TBL] [Abstract][Full Text] [Related]
7. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives.
Chie WC; Li CY; Huang CS; Chang KJ; Yen ML; Lin RS
Int J Cancer; 1998 Jul; 77(2):219-23. PubMed ID: 9650556
[TBL] [Abstract][Full Text] [Related]
8. Case-control study of oral contraceptive use and risk of breast cancer.
Rosenberg L; Palmer JR; Rao RS; Zauber AG; Strom BL; Warshauer ME; Harlap S; Shapiro S
Am J Epidemiol; 1996 Jan; 143(1):25-37. PubMed ID: 8533744
[TBL] [Abstract][Full Text] [Related]
9. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer.
Grabrick DM; Hartmann LC; Cerhan JR; Vierkant RA; Therneau TM; Vachon CM; Olson JE; Couch FJ; Anderson KE; Pankratz VS; Sellers TA
JAMA; 2000 Oct; 284(14):1791-8. PubMed ID: 11025831
[TBL] [Abstract][Full Text] [Related]
10. The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years.
Magnusson CM; Persson IR; Baron JA; Ekbom A; Bergström R; Adami HO
Int J Cancer; 1999 Jan; 80(2):231-6. PubMed ID: 9935204
[TBL] [Abstract][Full Text] [Related]
11. Oral contraceptives and breast cancer: review of the epidemiologic literature.
Thomas DB
Contraception; 1991 Jun; 43(6):597-642. PubMed ID: 1868735
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptives and breast cancer: a case-control study with hospital and community controls.
Schildkraut JM; Hulka BS; Wilkinson WE
Obstet Gynecol; 1990 Sep; 76(3 Pt 1):395-402. PubMed ID: 2381616
[TBL] [Abstract][Full Text] [Related]
13. Early oral contraceptive use and breast cancer among premenopausal women: final report from a study in southern Sweden.
Olsson H; Möller TR; Ranstam J
J Natl Cancer Inst; 1989 Jul; 81(13):1000-4. PubMed ID: 2733043
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer before age 45 and oral contraceptive use: new findings.
Miller DR; Rosenberg L; Kaufman DW; Stolley P; Warshauer ME; Shapiro S
Am J Epidemiol; 1989 Feb; 129(2):269-80. PubMed ID: 2912040
[TBL] [Abstract][Full Text] [Related]
15. p53 protein overexpression in relation to risk factors for breast cancer.
van der Kooy K; Rookus MA; Peterse HL; van Leeuwen FE
Am J Epidemiol; 1996 Nov; 144(10):924-33. PubMed ID: 8916503
[TBL] [Abstract][Full Text] [Related]
16. Cancer of the breast and reproductive tract in relation to use of oral contraceptives.
Schlesselman JJ
Contraception; 1989 Jul; 40(1):1-38. PubMed ID: 2673658
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer, serum antioxidant vitamins, and p53 protein overexpression.
Kim MK; Park YG; Gong G; Ahn SH
Nutr Cancer; 2002; 43(2):159-66. PubMed ID: 12588696
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use.
Pike MC; Henderson BE; Krailo MD; Duke A; Roy S
Lancet; 1983 Oct; 2(8356):926-30. PubMed ID: 6138501
[TBL] [Abstract][Full Text] [Related]
19. Oral contraceptives and breast cancer.
Jick H; Walker AM; Watkins RN; D'Ewart DC; Hunter JR; Danford A; Madsen S; Dinan BJ; Rothman KJ
Am J Epidemiol; 1980 Nov; 112(5):577-85. PubMed ID: 7435486
[TBL] [Abstract][Full Text] [Related]
20. Lifestyle and Reproductive Factors and Ovarian Cancer Risk by p53 and MAPK Expression.
Harris HR; Rice MS; Shafrir AL; Poole EM; Gupta M; Hecht JL; Terry KL; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2018 Jan; 27(1):96-102. PubMed ID: 29133366
[No Abstract] [Full Text] [Related]
[Next] [New Search]
